The rational combination of BRAF inhibition with immunotherapy for the treatment of metastatic melanoma

被引：0
|
作者：
Lizee, Gregory [1 ]
Liu, Chengwen [1 ]
Hwu, Patrick [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-PL03-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PL03-03
引用
收藏
页数：2
相关论文
共 50 条
  • [21] BRAF and MEK inhibition for the treatment of advanced BRAF mutant melanoma
    Richman, Juliet
    Martin-Liberal, Juan
    Diem, Stefan
    Larkin, James
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (09) : 1285 - 1297
  • [22] Inhibition of glucose metabolism through treatment of BRAF mutated metastatic melanoma with vemurafenib.
    Warrier, Govind
    Lanceta, Lilibeth
    Imbert-Fernandez, Yoannis
    Chesney, Jason Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [23] Encorafenib in combination with binimetinib for unresectable or metastatic melanoma with BRAF mutations
    Trojaniello, Claudia
    Festino, Lucia
    Vanella, Vito
    Ascierto, Paolo A.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (03) : 259 - 266
  • [24] Combination of RAF and MEK Inhibition for the Treatment of BRAF-Mutated Melanoma: Feedback Is Not Encouraged
    Chapman, Paul B.
    Solit, David B.
    Rosen, Neal
    CANCER CELL, 2014, 26 (05) : 603 - 604
  • [25] Combined BRAF and MEK inhibition in BRAF(V600E) mutant melanoma: a synergistic and potentially safe combination partner with immunotherapy
    Ott, Patrick A.
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (20)
  • [26] Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma
    Aya, F.
    Fernandez-Martinez, A.
    Gaba, L.
    Victoria, I.
    Tosca, M.
    Pineda, E.
    Gascon, P.
    Prat, A.
    Arance, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (01): : 119 - 124
  • [27] COMBINED BRAF AND MEK INHIBITION IMPROVES OUTCOME IN METASTATIC MELANOMA
    不详
    CANCER DISCOVERY, 2012, 2 (11) : 971 - 971
  • [28] Pyrexia as an adverse reaction to combination immunotherapy in metastatic melanoma
    Hebst, M.
    Herold, J. I.
    Emmert, S.
    Tietze, J. K.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 55 - 55
  • [29] Combination immunotherapy mitigated metastatic melanoma in early trial
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (06) : 1299 - 1299
  • [30] Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma
    F. Aya
    A. Fernandez-Martinez
    L. Gaba
    I. Victoria
    M. Tosca
    E. Pineda
    P. Gascon
    A. Prat
    A. Arance
    Clinical and Translational Oncology, 2017, 19 : 119 - 124
12345